The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect
Mar 21, 2012, 12:04 ET
NEW YORK, March 21, 2012 /PRNewswire/ -- Meghan Lopresto, VP, Sales Force Automation Analytics at The CementBloc, and Emad Abdelnaby, Director of Marketing at Novartis Vaccines, will be co-presenting their expertise in interactive selling at CBI's iPharmaConnect plenary session on March 27, 2012, in Philadelphia.
The conference is a 3-day symposium that will unite senior-level marketing, digital, brand, and medical affairs professionals to discuss novel approaches to thriving multichannel digital campaigns. From the client and agency perspectives, Ms. Lopresto and Mr. Abdelnaby will be presenting the success story behind the recently rolled-out program at Novartis Vaccines. Their talk, entitled, "Develop a Road Map for Transforming Your Organization Through Interactive Selling" will serve as an essential blueprint for optimizing iPad selling across an organization.
"Transitioning your field sales team over to an iPad platform is more than just an upgrade of their technology," says Ms. Lopresto. "It represents a key shift in the engagement between sales representatives and their customers. A successful rollout of these new tools requires a defined road map of the process, including agreed-upon core principles and buy-in from multiple stakeholders. If this is achieved, an organization can be transformed, for the better, through interactive selling."
At The CementBloc, Ms. Lopresto plays a key role in interactive selling tool development and measurement, multichannel marketing planning and analytics, promotional spend optimization, CRM/PRM, and closed-loop marketing initiatives. For more than 10 years, Meghan has been in the pharmaceutical industry in leadership roles, providing clients with innovative solutions for multichannel and professional advertising campaigns.
As Director of Marketing for the US Meningococcal Franchise at Novartis Vaccines and Diagnostics (NVD), Mr. Abdelnaby has responsibility for the development of professionally directed strategies and resources. Through his work at Novartis, Mr. Abdelnaby has helped to continue NVD's commitment to innovation in this space, including adoption of a broad-scale iPad platform for physician detailing, CRM, and sales training.
For more information or to register for iPharmaConnect, please contact CBI at 1-800-817-8601.
About The CementBloc: The CementBloc is a leading multichannel health and wellness creative agency based in New York. Founded in 2000 by Susan Miller and Rico Viray, The CementBloc is also a founding member of Indigenus, an independent global network of entrepreneurial healthcare creative agencies.
SOURCE The CementBloc
Share this article